Search Within

Neeta Pandit-Taskar

Formats
  1. Meeting Abstract (156)
  2. Journal Article (142)
  3. Review (20)
  4. Book Section (17)
  5. Guidelines (5)
  6. Editorial (2)
Groups
  1. Molecular Imaging and Therapy Service (342)
  2. Radiology, Department of (342)
  3. GSK Faculty (145)
  4. Medical Physics (126)
  5. Department of Medicine (120)
  6. Molecular Pharmacology and Chemistry Program Faculty (103)

More Groups

People
  1. Steven Larson (99)
  2. Jorge Carrasquillo (77)
  3. Pat Zanzonico (57)
  4. Jason Lewis (52)
  5. Serge Lyashchenko (52)
  6. Kim Kramer (51)

More People

Years
  1. 2025 (5)
  2. 2024 (21)
  3. 2023 (31)
  4. 2022 (33)
  5. 2021 (21)
  6. 2020 (12)

More Years

Publications
  1. Journal of Nuclear Medicine (66)
  2. Journal of Clinical Oncology (48)
  3. European Journal of Nuclear Medicine and Molecular Imaging (21)
  4. Pediatric Blood and Cancer (21)
  5. Neuro-Oncology (20)
  6. Blood (13)

More Publications

Publishers
  1. Society of Nuclear Medicine (66)
  2. Springer (49)
  3. American Society of Clinical Oncology (48)
  4. Elsevier Inc. (38)
  5. Oxford University Press (23)
  6. Wiley Periodicals, Inc (21)

More Publishers

Results (342)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Novel PET imaging techniques in the management of hematologic malignancies
    Editorial

    Nanni, C.; Castellucci, P.; Fanti, S.; Pandit-Taskar, N.
    PET Clinics (2024)

    Fulltext@MSK | Save
  • Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with (131)I-omburtamab for leptomeningeal disease
    Journal Article

    Prasad, K.; Serencsits, B. E.; Chu, B. P.; Dauer, L. T.; Donzelli, M.; Basu, E.; Kramer, K.; Pandit-Taskar, N.
    EJNMMI Research (2024)

    Fulltext@MSK | Save
  • A phase 0 study to assess the biodistribution and pharmacokinetics of a radiolabeled antibody targeting human kallikrein 2 in participants with metastatic castration-resistant prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Chetty, D.; Max, S.; Wanik, D.; Ilovich, O.; Russell, M.; Nyima, T.; Divgi, C. R.; Yu, M.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Management of metastatic pheochromocytomas and paragangliomas: When and what
    Review

    Sukrithan, V.; Perez, K.; Pandit-Taskar, N.; Jimenez, C.
    Current Problems in Cancer (2024)

    Fulltext@MSK | Save
  • Molecular imaging with PET-CT and PET-MRI in pediatric musculoskeletal diseases
    Review

    Guja, K. E.; Behr, G.; Bedmutha, A.; Kuhn, M.; Nadel, H. R.; Pandit-Taskar, N.
    Seminars in Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • (18)F-BMS-986229 PET to assess programmed-death ligand 1 status in gastroesophageal cancer
    Journal Article

    Cytryn, S. L.; Pandit-Taskar, N.; Lumish, M. A.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Antoine, A.; Loegel, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • High-dose targeted radiation with (131)I-apamistamab prior to HCT demonstrated a dose-response for durable complete remission in patients with R/R AML
    Meeting Abstract

    Litzow, M. R.; Chen, G.; Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Abboud, C. N.; Koshy, N.; Tomlinson, B. K.; Abhyankar, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Individualized dosing for high-dose targeted radiation of hematopoietic cells with Iomab-B (I131-apamistamab) prior to HCT in relapsed/refractory acute myeloid leukemia (R/R AML): Safety and efficacy results from the pivotal phase 3 SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Natwa, M.; Chen, M. K.; Wagner, R.; Yap, W.; Griffeth, L.; Wiseman, G.; Mhlanga, J.; Wahl, R.; Avril, N.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • 89Zr-DFO-girentuximab PET/CT imaging can accurately detect clear cell renal cell carcinoma primary and secondary lesions in patients with renal masses at conventional imaging, results from ZIRCON phase 3 study
    Meeting Abstract

    Calais, J.; Shuch, B.; Pantuck, A.; Bernhard, J. C.; Morris, M.; Master, V.; Scott, A.; van Praet, C.; Bailly, C.; Aksoy, T.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Dose-escalation study of [225Ac]-FPI-1434 (FPI-1434) in patients (pts) with IGF-1R expressing advanced solid tumors: Preliminary pharmacology and dosimetry results
    Meeting Abstract

    Pandit-Taskar, N.; Wong, J.; Subbiah, V.; Chenard-Poirier, M.; Pryma, D.; Berlin, A.; Juergens, R.; Puzanov, I.; Jacene, H.; Schindler, J.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save